BioDerm, Inc. Begins Distribution in Home Care Markets of a New Revolutionary Female Incontinence Device From TillaCare, Ltd
Health - Purple Foxy Ladies originally published at Health - Purple Foxy LadiesBioDerm, Inc., a leading provider of disposable medical devices and wound care supplies, announced a new distribution deal with TillaCare Ltd, an Israeli designer and manufacturer of external urine collection devices.
LARGO, Fla. - October 28, 2022 - (Newswire.com)
BioDerm is excited to partner with TillaCare as a U.S. distributor of TillaCare's UriCap Female. UriCap Female is a revolutionary external urine collection system offering female patients with urinary incontinence a comfortable, easy-to-use solution without the skin irritation and discomfort associated with absorbent products. Following the successful launch of UriCap Female in hospital and institutional settings, BioDerm launched a direct-to-consumer campaign allowing patients to receive UriCap Female for in-home use.
TillaCare began distribution of UriCap Female in 2019 into U.S. hospitals and institutions. Healthcare staff welcomed a modern solution for female acute patients suffering from urinary incontinence, replacing external suction-based or invasive catheters commonly causing infections as a side effect. Made of soft medical-grade silicone, UriCap Female is highly comfortable for the patient and connects to a standard urine bag. It supplies a leak-free alternative to traditional external female incontinence devices which typically include sticky adhesives or uncomfortable suction wands. UriCap Female does not require suction, is reimbursed by Medicare, and is safe for use for up to 24 hours. It is easily applied by qualified healthcare staff or self-applied by patients in their homes.
Headquartered in Largo, Florida, BioDerm is a leading provider of disposable medical devices and wound care supplies to patients with chronic conditions. BioDerm manufactures proprietary hydrocolloid products for urinary management, securement, infection control, and skin protection, challenging accepted inferior standards of care by creating products that reduce infection rates, add comfort and reliability, and vastly improve quality of life. BioDerm's flagship products for male urinary incontinence are Men's Liberty for the home setting and Men's Liberty Acute for in-patient settings. Other products include CathGrip for securement and BioPlus and FreeDerm for skin protection. Wound Care Resources ("WCR"), a subsidiary of BioDerm, provides infection control products and other wound management supplies to patients with ventricular assist devices (VADs) installed due to heart failure and other conditions.
For more information on BioDerm's line of products, visit www.bioderminc.com.
Dr. Kristi Campoe
TillaCare, Ltd. - U.S. Director of Clinical and Client Services
BioDerm, Inc. - Director of Marketing
Press Release - BioDerm UriCap_Final.docx
Press Release Service by Newswire.com
Original Source: BioDerm, Inc. Begins Distribution in Home Care Markets of a New Revolutionary Female Incontinence Device From TillaCare, Ltd
Health - Purple Foxy Ladies originally published at Health - Purple Foxy Ladies